Patents Assigned to State University
  • Publication number: 20180269483
    Abstract: A process for the facile prelithiation of silicon-containing materials for use in lithium ion batteries is disclosed. The process can include using a lithium additive comprising LiSt, Li2O—SiO2—TiO2—P2O5, LATP, LAGP, LLTO, LLZO, Li3N, LiBF4, Li2CO3, Li3PO4, lithium-enriched variations thereof, or combinations thereof. The resulting prelithiated materials demonstrate enhanced physicochemical properties providing for high target capacity and excellent cycle stability for the batteries prepared with the materials.
    Type: Application
    Filed: March 20, 2018
    Publication date: September 20, 2018
    Applicant: North Carolina Agricultural and Technical State University
    Inventor: Sungjin Cho
  • Publication number: 20180267072
    Abstract: The superposition of Laguerre-Gaussian guided into and scattered by a particle in a rotated fluid allows the detection of the rotational of the fluid. The presented system allows for virtually real-time determination of vorticity characterization in a fluid. The system allows the direct measurements of fluid flow vorticity using a spatially shaped beam with a superposition of Laguerre-Gaussian modes that reports on the rotational Doppler shift from microparticles intersecting the beam focus.
    Type: Application
    Filed: February 10, 2017
    Publication date: September 20, 2018
    Applicant: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
    Inventors: MARCOS DANTUS, MANOOCHEHR M. KOOCHESFAHANI, SHAHRAM POUYA, ANTON G. RYABTSEV, ALIREZA SAFARIPOUR TABALVANDANI
  • Patent number: 10078074
    Abstract: A system for measuring and tracking metabolic rate, physical activity and calorie intake. The metabolic rate is measured with a design that features an adaptive sampling mechanism for accurate breath sample collection, optimized flow rate measurement for minimizing backpressure while maximizing accuracy, humidity regulation and water condensation reduction mechanism for reliable performance, as well as breath temperature measurement for volume and humidity corrections. The system further comprises an improved algorithm for determining physical activity such as related energy expenditure, and a mechanism for tracking changes in food intake over time.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: September 18, 2018
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Francis Tsow, Xiaojun Xian, Erica Forzani, Nongjian Tao
  • Patent number: 10077356
    Abstract: The present application relates generally to bio-adhesive components isolated from bio-oil prepared from animal waste, methods of preparation of the bio-adhesive components and uses thereof. Such uses include, but are not limited to, asphalt bio-binders, bio-adhesion promoters, asphalt bio-rejuvenators, asphalt bio-extenders, bio-asphalt as well as uses in roofing, soil stabilization, crack and joint sealing and flooring adhesives.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: September 18, 2018
    Assignee: North Carolina Agricultural and Technical State University
    Inventor: Elham H. Fini
  • Patent number: 10078733
    Abstract: An apparatus comprising a natural language processor, a mapper, a string comparator, a nutrient calculator, and a diet planning module, the diet planning module configured to generate a diet action control, the diet action control comprising instructions to operate the client device to perform a diet change recommendation on the client device, and apply the diet action control to the client device.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: September 18, 2018
    Assignee: WASHINGTON STATE UNIVERSITY
    Inventors: Hassan Ghasemzadeh, Niloofar Hezarjaribi
  • Patent number: 10079003
    Abstract: Methods and systems of displaying an image of an object are described. The displayed image is comprised of at least two parts that are displayed so as to present a unified image of the object. One part of the image is derived using a first temporal filter and the other part of the image is derived using a second temporal filter.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: September 18, 2018
    Assignee: The Research Foundation for the State University of New York
    Inventors: Stephen Rudin, Daniel R. Bednarek
  • Patent number: 10076481
    Abstract: Compositions comprising serine and an organic mono- or multi-phosphate salt and methods of using such compositions to treat and/or prevent periodontal disease and/or dental calculus are provided.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: September 18, 2018
    Assignee: The Research Foundation for the State University of New York
    Inventors: Israel Kleinberg, Robi Chatterjee
  • Patent number: 10078494
    Abstract: This disclosure relates generally to physically unclonable function (PUF) circuitry along with methods of generating numbers. In one embodiment, the PUF circuitry includes a memory, a memory control circuitry, and whitening circuitry. To reduce or eliminate the systematic bias from the array, whitening circuitry is configured to generate a random number comprising random number bits in response to the memory control circuit implementing at least one sequence of memory cycles on the array of the memory cells in the memory. The whitening circuitry is configured to provide the random number bits of the random number based on the variable bit states stored by the array of the memory cells. On average the whitening circuitry is configured to provide approximately half of the random number bits in the first bit state and half of random number bits in a second bit state.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: September 18, 2018
    Assignee: Arizona Board of Regents on behalf of Arizona State University
    Inventors: Lawrence T. Clark, James Adams, Keith E. Holbert
  • Patent number: 10076574
    Abstract: Methods for treating a subject in need thereof are provided which include administering a pharmaceutical composition comprising a protein transduction reagent-modified reprogramming protein to the subject, wherein the protein transduction reagent is non-covalently bound to the reprogramming protein and wherein the protein transduction reagent comprises a cation reagent and a lipid. According to aspects, such methods provide delivery of protein-transduction reagent-modified reprogramming proteins to cancer cells, such as tumor cells, as well as diseased cells of diseased tissues and provide in vivo conversion of diseased cells into normal cells via protein-induced in situ cell reprogramming without administration of nucleic acids to the subject.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: September 18, 2018
    Assignee: Wayne State University
    Inventors: Jianjun Wang, Qianqian Li, Michael Chopp, Feng Jiang, Guojun Wu
  • Patent number: 10077278
    Abstract: The disclosure is directed to diboron compounds, related methods of making, and related intermediate boron and diboron compounds used to make the same. The diboron compounds can be used as reagents to prepare chemical intermediates that are used in pharmaceutical, agrochemical, and specialty electronics industries. The disclosed processes and compounds provide simplified synthetic paths that significantly reduce steps, improve scalability, and minimize costs for producing the diboron reagents.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: September 18, 2018
    Assignee: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
    Inventors: Milton R. Smith, III, Robert E. Maleczka, Jr.
  • Patent number: 10077257
    Abstract: Various embodiments disclosed relate to aziridinated triglycerides and polymers formed therefrom. In various embodiments, the present invention provides an aziridinated triglyceride having the structure described herein. In various embodiments, the present invention provides a method of making the aziridinated triglyceride, a method of crosslinking the aziridinated triglyceride to form a polymer, the polymer formed from the aziridinated triglyceride, a triglyceride with at least one pendent unsaturated group that can be used to form the aziridinated triglyceride, and a method of making the triglyceride having at least one pendent unsaturated group.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: September 18, 2018
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Ruqi Chen, Jason Shih-Hao Chen, Chaoqun Zhang, Michael Richard Kessler
  • Publication number: 20180257989
    Abstract: A composition comprising: (a) fly ash cementitious binder; and (b) a chemical activator selected from sodium silicate, potassium silicate, sodium sulfate, sodium phosphate, calcium sulfate, potassium sulfate, potassium phosphate, CaO, Fe2O3, sodium chloride, calcium chloride, fine fraction of concrete waste from construction or demolition, cement kiln dust, or a combination thereof, wherein the fly ash is the only cementitious binder present in the composition and the CaO activator, if present, is present in an amount ?10 weight percent, based on the total dry weight of the composition.
    Type: Application
    Filed: August 26, 2016
    Publication date: September 13, 2018
    Applicant: Washington State University
    Inventors: Xianming Shi, Gang Xu
  • Publication number: 20180258148
    Abstract: The invention provides inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE).
    Type: Application
    Filed: September 9, 2016
    Publication date: September 13, 2018
    Applicant: Rutgers, The State University of New Jersey
    Inventor: Betsy J. BAMES
  • Publication number: 20180255738
    Abstract: Compositions and methods for reducing the level of nornicotine and N?-nitrosonornicotine (NNN) in tobacco plants and plant parts thereof are provided. The compositions comprise isolated polynucleotides and polypeptides for a root-specific nicotine demethylases, CYP82E10, and variants thereof, that are involved in the metabolic conversion of nicotine to nornicotine in these plants. Compositions of the invention also include tobacco plants, or plant parts thereof, comprising a mutation in a gene encoding a CYP82E10 nicotine demethylase, wherein the mutation results in reduced expression or function of the CYP82E10 nicotine demethylase. Seed of these tobacco plants, or progeny thereof, and tobacco products prepared from the tobacco plants of the invention, or from plant parts or progeny thereof, are also provided. Methods for reducing the level of nornicotine, or reducing the rate of conversion of nicotine to nornicotine, in a tobacco plant, or plant part thereof are also provided.
    Type: Application
    Filed: June 29, 2017
    Publication date: September 13, 2018
    Applicant: North Carolina State University
    Inventors: Ralph E. Dewey, Ramsey S. Lewis
  • Publication number: 20180261843
    Abstract: Bimetallic polyanionic materials, such as silver vanadium phosphorus oxide (Ag2VO2PO4, SVOP), are promising cathode materials for Li batteries due in part to their large capacity and high current capability. A new synthesis of Ag2VO2PO4 based on microwave heating is disclosed, where the reaction time is reduced by approximately 100 times relative to other reported methods, and the crystallite size is controlled via synthesis temperature, showing a linear positive correlation of crystallite size with temperature. Reaction times of an hour or less are sufficient to render phase-pure material after reaction at 50° C. to 180° C., significantly lower than the temperatures reported for other methods. Crystallite sizes between 42 nm and 60 nm are achieved by the novel method, smaller than by other methods. Silver/vanadium atomic ratios of 1.96 to 2.04 in the as-synthesized SVOP result and appear temperature-dependent.
    Type: Application
    Filed: March 7, 2018
    Publication date: September 13, 2018
    Applicant: The Research Foundation for The State University of New York
    Inventors: Kenneth J. TAKEUCHI, Esther S. TAKEUCHI, Amy C. MARSCHILOK
  • Publication number: 20180259230
    Abstract: Standalone and self-contained cooling systems using compressed liquid and/or gas CO2 containers positioned in an insulated or non-insulated vessel and consisting of a specially designed unit where the containers are vertically positioned in an upright or upside-down position. The liquid and/or gas CO2 coolant is then released into capillary tube(s) embedded into a heat transfer plate or heat exchanger thus leveraging the CO2 coolant properties. The temperature is controlled by a metering CO2 releasing system encompassing an electronic control device which can be operated remotely and/or via a touch screen and which sends alerts when pre-defined thresholds are exceeded. The invention's metering CO2 releasing system may be triggered by an electronic or a thermostatic valve or may be triggered manually or by an electronic solenoid. The invention's cooling system also encompasses check valves, which avoid liquid and/or gas CO2 from escaping when removing or replacing CO2 containers individually.
    Type: Application
    Filed: May 13, 2018
    Publication date: September 13, 2018
    Applicants: Frostime LLC, NORTH DAKOTA STATE UNIVERSITY
    Inventors: Mark Holzwanger, Xianghong Henry Liu, Heng Hu, Harry Holzwanger, Maria Grazia Verardi, Robert A. Sailer, Justin Hoey
  • Publication number: 20180258433
    Abstract: Compositions and methods for treating hypertension in a subject are provided, including administering an antisense oligomer effective to reduce expression of cytochrome P450 3A5 (CYP3A5) enzyme. The antisense oligomer includes phosphorodiamidate morpholino oligonucleotide (PMO), phosphorothioate 2?-O-methyl oligoribonucleotides (PSO), locked nucleic acid nucleotide, locked nucleic acid analog nucleotide, or another modified oligonucleotide backbone or nuclease-resistant backbone. The antisense oligomer is administered transdermally, subcutaneously, or orally, and optionally with a pharmaceutically acceptable carrier. In one embodiment, the antisense oligomer is an oligomer that is antisense to mRNAs that encode CYP3A5, for instance targeted at the AUG start site of the mRNAs that encode CYP3A5 or at a G4 structure within CYP3A5.
    Type: Application
    Filed: September 2, 2016
    Publication date: September 13, 2018
    Applicant: Oregon State University
    Inventors: Patrick L. Iversen, Andrew J. Annalora
  • Publication number: 20180256891
    Abstract: Example devices and methods of tongue stimulation for communication of information to a user are disclosed herein. In an example, a tongue stimulation device may include a body configured to be placed entirely within a mouth of the user and atop the tongue of the user. An array of electro-tactile elements may be distributed on the body, wherein each of the electro-tactile elements is configured to stimulate an area of the tongue adjacent the electro-tactile element. A wireless receiver coupled to the body may be configured to receive stimulation information wirelessly from outside the mouth of the user. At least one processing unit coupled to the body may be configured to transform the received stimulation information into a stimulation signal for each of the electro-tactile elements, and to provide the stimulation signals to the electro-tactile elements.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Applicant: Colorado State University Research Foundation
    Inventors: John D. Williams, Joel A. Moritz, Leslie M. Stone-Roy
  • Publication number: 20180256045
    Abstract: Most automatic cuff blood pressure (BP) measurement devices are based on oscillometry. These devices estimate BP from the envelopes of the cuff pressure oscillations using fixed ratios. The values of the fixed ratios represent population averages, so the devices may be accurate only in subjects with normal BP levels. A patient-specific oscillometric BP measurement method was developed. The idea was to represent the cuff pressure oscillation envelopes with a physiologic model and then estimate the patient-specific parameters of the model, which includes BP levels, by optimally fitting it to the envelopes.
    Type: Application
    Filed: September 9, 2016
    Publication date: September 13, 2018
    Applicants: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY, UNIVERSITY OF MARYLAND
    Inventors: Jiankun LIU, Mohsen MOSLEHPOUR, Jin-Oh HAHN, Ramakrishna MUKKAMALA
  • Publication number: 20180258381
    Abstract: Disclosed herein are embodiments of bio-lamina bioreactors and methods of making and using the same. The bio-lamina bioreactors disclosed herein can make fuels from organic reactants using fluid flow through the bio-lamina bioreactors in combination with microorganisms capable of reacting with the organic reactants. The microorganisms are embedded within biofilms present within the bio-lamina bioreactor. The bio-lamina bioreactor further comprises bio-lamina substrates comprising unique flow channels and structural projections that facilitate fluid flow and interactions with the microorganism cultures of the biofilm.
    Type: Application
    Filed: May 16, 2018
    Publication date: September 13, 2018
    Applicant: Oregon State University
    Inventors: Goran Nadezda Jovanovic, Kate Schilke, Chris Loeb, Frederick Atadana, Davis Weymann